Eyegate Pharmaceuticals, Inc.

EyeGate Pharma (NASDAQ: EYEG) is a late-stage clinical company focused on developing for treating disorders of the eye. EyeGate’s lead product, Ocular Bandage Gel (“OBG”), is based on a modified form of the natural polymer hyaluronic acid. The product is applied as a clear topical gel, to the damaged ocular surface and possesses unique properties that help hydrate, protect, and heal the…More ocular surface.